X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (521) 521
index medicus (298) 298
humans (277) 277
hepacivirus - genetics (127) 127
female (119) 119
male (119) 119
virology (117) 117
hepatitis c virus (111) 111
adult (103) 103
hepatitis c (103) 103
middle aged (101) 101
antiviral agents - therapeutic use (92) 92
genotype (81) 81
infection (78) 78
gastroenterology and hepatology (71) 71
hepatitis c, chronic - drug therapy (70) 70
infectious diseases (67) 67
hepacivirus - drug effects (56) 56
rna (56) 56
aged (55) 55
hepatitis (54) 54
interferon (53) 53
interferon-alpha - therapeutic use (53) 53
abridged index medicus (52) 52
life sciences (52) 52
virus diseases (49) 49
drug therapy, combination (45) 45
hepatitis c - virology (44) 44
hepatitis c, chronic - virology (44) 44
ribavirin (44) 44
therapy (44) 44
health aspects (43) 43
microbiology (43) 43
ribavirin - therapeutic use (42) 42
treatment outcome (42) 42
rna, viral - blood (41) 41
viral load (40) 40
hepatitis c - drug therapy (38) 38
hepacivirus - isolation & purification (37) 37
antiviral agents - pharmacology (36) 36
antiviral agents (33) 33
pharmacology & pharmacy (33) 33
polymerase chain reaction (33) 33
recombinant proteins (33) 33
virus-infection (33) 33
biochemistry, molecular biology (32) 32
plus ribavirin (31) 31
hepatitis c - diagnosis (30) 30
digestive system diseases (29) 29
genotypes (29) 29
rna, viral - analysis (29) 29
sensitivity and specificity (29) 29
biological response modifiers (28) 28
hcv (28) 28
hepacivirus (28) 28
hepacivirus - immunology (28) 28
hepacivirus - physiology (26) 26
[ sdv.bbm ] life sciences [q-bio]/biochemistry, molecular biology (25) 25
hepacivirus - classification (25) 25
hepatitis c, chronic - complications (24) 24
molecular sequence data (24) 24
peginterferon alpha-2a (24) 24
rna, viral - genetics (24) 24
sustained virological response (24) 24
animals (23) 23
drug therapy (23) 23
immunology (23) 23
viral nonstructural proteins - genetics (23) 23
viruses (23) 23
drug resistance, viral (22) 22
hepatitis b virus (22) 22
hepatitis b virus - genetics (22) 22
hepatitis c, chronic - diagnosis (22) 22
infections (22) 22
polyethylene glycols - therapeutic use (22) 22
hepatocellular-carcinoma (21) 21
in-vitro (21) 21
prevalence (21) 21
antiviral agents - administration & dosage (20) 20
care and treatment (20) 20
liver (20) 20
telaprevir (20) 20
time factors (20) 20
cirrhosis (19) 19
hepatitis b (19) 19
hepatitis c - complications (19) 19
hepatitis c - epidemiology (19) 19
hepatitis c antibodies - blood (19) 19
polymerase chain-reaction (19) 19
resistance (19) 19
risk factors (19) 19
amino acid sequence (18) 18
analysis (18) 18
antibodies (18) 18
hcv rna (18) 18
medicine, general & internal (18) 18
fibrosis (17) 17
france (17) 17
genetic aspects (17) 17
hepatitis c - immunology (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, ISSN 1759-5045, 12/2015, Volume 12, Issue 12, pp. 673 - 674
Treatment failure associated with HCV resistance to newly developed direct-acting antiviral agents is not an uncommon occurrence and poses a substantial... 
VARIANTS | COMBINATION | GASTROENTEROLOGY & HEPATOLOGY | NS5A | HEPATITIS-C | Antiviral agents | Usage | Care and treatment | Proteases | Dosage and administration | Research | Biological response modifiers | Hepatitis C | Risk factors | RNA polymerases
Journal Article
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, ISSN 1759-5045, 05/2017, Volume 14, Issue 5, pp. 264 - 265
A new study provides an important proof-of-concept that viral replication can be substantially reduced for several weeks by a single injection of a... 
INFECTION | RNA | GASTROENTEROLOGY & HEPATOLOGY | HEPATITIS-C
Journal Article
Hepatology, ISSN 0270-9139, 11/2016, Volume 64, Issue 5, pp. 1404 - 1407
Journal Article
Gut, ISSN 0017-5749, 08/2014, Volume 64, Issue 3, pp. 362 - 363
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1453 - 1464
Although direct-acting antivirals have been used extensively to treat patients with chronic hepatitis C virus (HCV) infection, their clinical effectiveness has... 
SUSTAINED VIROLOGICAL RESPONSE | ALL-CAUSE MORTALITY | SURVIVAL | FIBROSIS | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | VIRUS-INFECTION | THERAPY | LIVER | RISK | ERADICATION | Carcinoma, Hepatocellular - epidemiology | Hepatitis C, Chronic - pathology | Prospective Studies | Antiviral Agents - therapeutic use | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - mortality | Incidence | Liver Cirrhosis - epidemiology | Liver Neoplasms - epidemiology | Adult | Female | Aged | France | Antiviral agents | Care and treatment | Hepatitis C | Patient outcomes | Syngeneic grafts | Liver | Medical services | Chronic infection | Viruses | Hepatocellular carcinoma | Alcohol | Transplantation | Infections | Ribavirin | Hepatitis | Time dependence | Liver cancer | Sexually transmitted diseases | Allografts | Human immunodeficiency virus--HIV | Hepatitis B virus | Genotypes | Hypertension | Liver diseases | Mortality | Diabetes mellitus | Risk reduction | Proteinase inhibitors | Hazards | Exposure | Patients | Studies | Cirrhosis | Statistical models | Protease inhibitors | Fibrosis | Interferon | Hepatitis C virus | Health risk assessment | Risk management | Hepatitis B | Liver transplantation | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article